| Tretinoin | Approved Investigational Nutraceutical | CDH11 | 1009 |
downregulated | Tretinoin results in decreased expression of CDH11 mRNA | 16q21 | |
| Tretinoin | Approved Investigational Nutraceutical | CDH11 | 1009 |
upregulated | Tretinoin results in increased expression of CDH11 mRNA | 16q21 | |
| Tretinoin | Approved Investigational Nutraceutical | CDH12 | 1010 |
upregulated | Tretinoin results in increased expression of CDH12 mRNA | 5p14.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CDH13 | 1012 |
upregulated | Tretinoin results in increased expression of CDH13 mRNA | 16q23.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CDH24 | 64403 |
downregulated | Tretinoin results in decreased expression of CDH24 mRNA | 14q11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CDH3 | 1001 |
upregulated | Tretinoin results in increased expression of CDH3 mRNA | 16q22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | CDH5 | 1003 |
upregulated | Tretinoin results in increased expression of CDH5 mRNA | 16q21 | |
| Tretinoin | Approved Investigational Nutraceutical | CDH6 | 1004 |
downregulated | Tretinoin results in decreased expression of CDH6 mRNA | 5p13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CDH7 | 1005 |
upregulated | Tretinoin results in increased expression of CDH7 mRNA | 18q22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | CDH9 | 1007 |
downregulated | Tretinoin results in decreased expression of CDH9 mRNA | 5p14.1 | |
| Tretinoin | Approved Investigational Nutraceutical | CDK1 | 983 |
downregulated | Tretinoin results in decreased expression of CDK1 mRNA | 10q21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CDK14 | 5218 |
downregulated | Tretinoin results in decreased expression of CDK14 mRNA | 7q21.13 | |
| Tretinoin | Approved Investigational Nutraceutical | CDK16 | 5127 |
upregulated | Tretinoin results in increased expression of CDK16 mRNA | Xp11.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CDK5R1 | 8851 |
upregulated | Tretinoin results in increased expression of CDK5R1 mRNA | 17q11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CDK6 | 1021 |
upregulated | Tretinoin results in increased expression of CDK6 mRNA | 7q21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CDK8 | 1024 |
downregulated | Tretinoin results in decreased expression of CDK8 mRNA | 13q12.13 | |
| Tretinoin | Approved Investigational Nutraceutical | CDK9 | 1025 |
upregulated | Tretinoin results in increased expression of CDK9 mRNA | 9q34.11 | |
| Tretinoin | Approved Investigational Nutraceutical | CDKL5 | 6792 |
upregulated | Tretinoin results in increased expression of CDKL5 mRNA | Xp22.13 | |
| Tretinoin | Approved Investigational Nutraceutical | CDKN1A | 1026 |
downregulated | Tretinoin results in decreased expression of CDKN1A mRNA | 6p21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CDKN1A | 1026 |
upregulated | Tretinoin results in increased expression of CDKN1A mRNA | 6p21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CDKN1B | 1027 |
upregulated | Tretinoin results in increased expression of CDKN1B mRNA | 12p13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | CDKN1C | 1028 |
downregulated | Tretinoin metabolite results in decreased expression of CDKN1C mRNA | 11p15.4 | |
| Tretinoin | Approved Investigational Nutraceutical | CDKN1C | 1028 |
downregulated | Tretinoin results in decreased expression of CDKN1C mRNA | 11p15.4 | |
| Tretinoin | Approved Investigational Nutraceutical | CDKN2A | 1029 |
downregulated | Tretinoin results in decreased expression of CDKN2A mRNA | 9p21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CDKN2A | 1029 |
upregulated | Tretinoin results in increased expression of CDKN2A mRNA | 9p21.3 | |